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1.1. Combinatorial approaches to combating multidrug
resistance with antimicrobial peptides
The widespread use of antibiotics throughout the world has
led to bacterial resistance to many commonly used antibi-
otics. Development of resistance, coupled to the fact that
only a few new classes of antibacterial agents have been
introduced into the clinic during the last decade, has
emphasised the need for novel antibiotic development. To
meet this need, cationic antimicrobial peptides (CAPs)
are a promising class of future antibacterial agents. They
are believed less likely to induce resistance in bacteria,
and this lower propensity for resistance may arise from
their unique mechanism of action. Although no exact mode
of action has been established, most antimicrobial peptides
are thought to act on, or at least to involve, bacterial mem-
branes. Several models have been put forward to explain
the interactions between CAPs and bacterial membranes,
but no common view has been reached to date.
Several challenges remain in the development of CAPs into
drugs. However, one promising approach has been the
development of small molecular weight CAPs. In a recent
study, a library of tripeptide derivatives containing the
unnatural amino acid 4-iodophenylalanine has been pre-
pared using a Rink amide linker solid support.1
These novel tripeptides (i) were synthesised through Suzu-
ki–Miyaura cross-coupling reactions, and tested for their
ability to inhibit the growth of Streptococcus pyogenes,
S. aureus, methicillin-resistant S. aureus (MRSA), and
methicillin-resistant S. epidermidis (MRSE). The results
obtained were expressed as the minimal inhibitory concen-
tration (MIC) in lM. Of the peptides synthesised and
tested, generally all of the derivatives displayed signiﬁcantdoi:10.1016/j.comche.2007.04.001
E-mail: nterrett@ensemblediscovery.comincreases in antimicrobial activity compared to control
peptides. S. pyogenes was found to be the least susceptible
bacterium in the test panel, while all peptides were most
active against MRSE. One of the most potent peptides iso-
lated was (ii) which possessed a MIC of 16 lM against S.
pyogenes and a MIC of 4.1 lM against MRSE. In addition,
the peptides were also tested for haemolytic activity against
human erythrocytes. Most of the peptides were found to be
non-haemolytic within the concentration range tested (up
to 500 lg/mL).
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In summary, the low haemolytic propensity of these pep-
tides in combination with their high antimicrobial activity
increases the chances that such entities could be developed
into clinical candidates, allowing for the future develop-
ment of drugs eﬀective against multidrug resistant
pathogens.
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2-deacetoxytaxinine J
Paclitaxel (Taxol) is a complex natural diterpene extracted
fromTaxus brevifolia. Paclitaxel and its derivative docetaxel
are two of the more important anticancer agents for the
treatment of ovarian and breast cancer. The use in a clinical
setting of anticancer drugs such as these have revealed a
number of undesirable side eﬀects and multidrug resistance
(MDR) induced by taxoid treatment in tumour cells is an
obstacle to the successful application of chemotherapy.
MDR is a phenomenon whereby tumour cells that have
been exposed to one cytotoxic agent develop cross resis-
tance to a range of structurally and functionally unrelated
compounds. The drug resistance developed in cancer cells
may be controlled by many mechanisms. One postulated
mechanism relates to the over-expression in cancer cells
of particular proteins such as P-glycoprotein (P-gp) which
expel hydrophobic anticancer compounds and maintain
intracellular concentrations below a cytotoxic level.
Among the natural taxoids, 2-deacetoxytaxinine J (DAT-J)
(iii) has emerged as an active P-gp inhibitor with a potency
higher than verapamil. DAT-J is extracted in low amounts
from several yew species, but it can be synthesised from the
natural alkaloid 2’-deacetoxyaustropicatine (DAS) (iv)
available in multigram amounts from Taxus x media Rehd.
Cv. HicKsii. Additionally, unlike other cinnamates related
to taxinine, DAT-J does not show cardiotoxicity, and thusO
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(vi)may provide an important starting material for the synthe-
sis of new reversal agents.
For these reasons, the development of methods for the
preparation of new bioactive taxinine analogues from
DAT-J, is desirable. Recent work has reported on the prep-
aration of a small library of DAT-J analogues (v) and their
biological screening as new putative MDR-reversing agents
against multidrug-resistant breast tumour cell lines.2
Biological evaluation of DAT-J analogues of general struc-
ture (v) synthesised in this work were tested in vitro for
their MDR revertant activity in human mammary carci-
noma cell line MCF7-R; this cell line being resistant to pac-
litaxel. The compounds were tested at a non-cytotoxic
concentration (1.0 and 0.1 lM) in combination with paclit-
axel. The activity was expressed as an IC50 (in nM); the
concentration required to cause 50% inhibition of cancer
cell growth. One of the most potent compounds synthe-
sized and tested was (vi) which possessed an IC50 of 31 nM.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
The ﬁrst regiocontrolled solid-phase synthesis of a 2,6,8,9-
tetrasubstituted purine library has been performed through
on-resin elaboration of 4,6-dichloro-2-(methylthio)-5-
nitropyrimidine. Most of the ﬁnal purines were cleaved in
good to excellent yield and purity. However it was found
that bulky groups at N9 hindered cyclisation in C8-substi-
tuted derivatives.3
2.2. Solution-phase synthesis
Various palladium-catalysed cascade reactions of O-alkyl-
ated 2-iodophenol have been explored in order to synthe-
sise novel dihydrobenzofurans, and a small library of
these compounds was prepared with a parallel organic
synthesiser.4
The condensation reaction of 2-amino-3-hydroxypyridine
with diﬀerent carboxylic acids by microwave-assisted
heating has been shown to be a fast method for producing
libraries based on fused 2-substituted oxazolo[4,5-b]-
pyridines.5
A highly eﬃcient one-pot, two-step microwave procedure
has been developed for the synthesis of 4-substituted 1-het-
eroarylpiperazines. Microwave heating of heteroaryl chlo-
rides with 1,4-diazabicyclo[2.2.2]octane (DABCO) yielded
1-heteroaryl-4-(2-chloroethyl)piperazines, which could be
further reacted with various nucleophiles, again under
microwave irradiation conditions, to give an array of 4-
substituted 1-heteroarylpiperazines in good to excellent
yields.6
2.3. Scaﬀolds for combinatorial libraries
Optimisation of coupling reactions of glycosylamines with
Fmoc-protected aspartic acid, by microwave approach, has
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substrates and solvents were tested to develop simple and
reproducible methodologies, and the N-glycosyl amino
acids were deprotected to achieve ﬁnal products for SPPS.7
Preparation of the 4 0,4 0-C-diaminomethyl uridine analogue
starting from the commercial uridine via 4 0,4 0-C-dihydr-
oxymethyl uridine, 4 0,4 0-C-bis-triﬂuoromethanesulphonyl-
oxymethyl uridine, and 4 0,4 0-C-diazidomethyl uridine in
total eight steps was achieved in 8% yield. The product
has been used as a scaﬀold for library production.8
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
No papers this month.
2.6. Library applications
Novel arylpiperazines with N-acylated amino acids,
selected on the basis of a preliminary screening of two
libraries previously synthesised on SynPhaseTM Lanterns,
have been prepared in solution and their aﬃnity for 5-
HT1A, 5-HT2A, and D2 receptors evaluated.
9
A 23-member C2-aryl pyrrolo[2,1-c][1,4]benzodiazepine-
5,11-dione (PBD dilactam) library has been synthesised
using Suzuki coupling, and the eﬀect of base upon racemi-
sation at the C11a-position during the cross-coupling reac-
tion studied. Three library members were suﬃciently
cytotoxic in the NCI’s preliminary screen to warrant fur-
ther evaluation.10
The identiﬁcation of constitutively activated STAT (Signal
Transducers and Activators of Transcription) proteins in
aberrant cell signalling pathways has led to investigations
targeting the selective disruption of speciﬁc STAT isoforms
directly associated with oncogenesis. Through the design of
a library of peptidomimetic inhibitors, agents that selec-
tively disrupt STAT1 or STAT3 homo-dimerisation at
low micromolar concentrations have been discovered.11
The guanylhydrazone of 2-(4-chlorobenzyloxy)-5-bromo-
benzaldehyde, a CCR5 receptor ligand, was identiﬁed using
high-throughput screening. Optimisation eﬀorts led to the
discovery of a novel piperidine series of CCR5 antagonists,
and the 4-hydroxypiperidine derivative was a starting point
for further optimisation using parallel synthesis.12
A library of potential antifungal triazole-modiﬁed b-meth-
oxyacrylate analogues was designed and synthesised via a
Cu(I)-catalyzed 1,3-dipolar alkyne-azide coupling reaction
or ‘click chemistry’. Subsequent biological screening
revealed that some compounds displayed low to moderate
antifungal activity toward pathogenic fungi and low
phytotoxicity.13
A novel series of pyrrolidine-constrained phenethylamines
were developed as dipeptidyl peptidase IV (DPP4) inhibi-tors for the treatment of type 2 diabetes. Using parallel
chemistry, and protein co-crystal structural data to guide
the optimisation of N-substituents, a >400 · improvement
in potency over the initial hit was realised.14
A series of heterobiaryl amides was designed and synthes-
ised as novel mGluR5 antagonists. The synthesis using pal-
ladium catalyzed Suzuki–Miyaura cross-coupling reactions
provided an array of compounds with a range of in vitro
activities.15
In the course of a high throughput screening, a series of
pyrazole compounds were identiﬁed with luteinising hor-
mone receptor (LH-R) agonist activity. A focused pyrazole
library was produced by solid-phase synthesis and key pyr-
azole regioisomers were obtained selectively in solution.16
Inhibitors of histone deacetylase (HDAC) proteins such as
suberoylanilide hydroxamic acid (SAHA) have emerged as
eﬀective therapeutic anti-cancer agents. To better under-
stand the structural requirements of HDAC inhibitors, a
small molecule library with a variety of substituents
attached adjacent to the metal binding hydroxamic acid
of SAHA was synthesised.17
Halopemide, which was identiﬁed by HTS to inhibit phos-
pholipase D2 (PLD2), provided the basis for an explor-
atory eﬀort to identify potent inhibitors of PLD2 for use
as inﬂammatory mediators. Parallel synthesis and puriﬁca-
tion were used to rapidly identify orally available amide
analogues derived from indole 2-carboxylic acids with
superior potency versus PLD2.18
A novel series of potent dual agonists of PPARa and
PPARc, the alkoxybenzylglycines, has been identiﬁed and
explored using a solution-phase library approach.19
The synthesis of a selected library of heterochiral d-
Pro-containing RGD-peptidomimetics (RpD) has been
described and these compounds were investigated as inhibi-
tors of ﬁbronectin adhesion to SK-MEL-24 tumour cells.20
The discovery of novel antibacterial agents which were rap-
idly optimised utilizing a parallel chemistry approach has
been described. In an eﬀort to decrease the aﬃnity for
HSA, a series of heterocyclic analogues were prepared
and these retained antibacterial activity and demonstrated
reduced aﬃnity for HSA.21
A novel, general and versatile method of diversiﬁcation of
the P1 0 position in phosphinic pseudodipeptides, presum-
able inhibitors of proteolytic enzymes, has been elaborated.
The procedure was based on parallel derivatisation of the
amino group in the suitably protected phosphinate build-
ing blocks with appropriate alkyl and aryl halides. The
compounds were evaluated as inhibitors of cytosolic leu-
cine aminopeptidase and aminopeptidase N.22
A series of 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phen-
ylbutanes comprising imidazole–ketones, imidazole–diox-
olanes and imidazole–alcohols substituted with halogens
in the phenyl ring have been synthesised and evaluated as
24 N. K. Terrett / Combinatorial Chemistry - An Online Journal 9 (2007) 21–25novel inhibitors of heme oxygenase which are structurally
distinct from metalloporphyrins.23
The parallel acylation of N-{3-[4-(3-aminopropyl)pipera-
zin-1-yl]propyl}-7-chloroquinolin-4-amine with polymer-
bound carboxylic acids has provided a straightforward
access to novel aminoquinolines with activity against
Plasmodium falciparum strains in vitro.24References
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